RSS Feed
 |
New FDA ruling regarding Drospirenone: Birth control pills containing the progesterone, Drospirenone, have been shown to be associated with a three-fold increased risk of blood clots. This issue does not raise the concern to the level where the drug should be prohibited. FDA does however suggest that this issue should be discussed with the patient [...] [ Read More on ExamPro Announces Exam-Relevant OB/GYN News Regarding Drospirenone ] |
Exampro Tips and Techniques
ExamPro Announces Exam-Relevant OB/GYN News Regarding Drospirenone
Monday, April 16th, 2012ExamPro Announces OB/GYN Exam Relevant Information – Recent Changes to Cervical Cancer Screening
Monday, March 19th, 2012 |
The US Preventative Services Task Force (USPSTF) and the American Cancer Association (ACS) recently made subtle changes to their recommendations regarding cervical cancer screening. The changes are as follows: 1) Whereas the USPSTF previously did not recommend combined testing comprising cervical cytology and high risk HPV testing, they now state there is sufficient evidence to warrant [...] [ Read More on ExamPro Announces OB/GYN Exam Relevant Information – Recent Changes to Cervical Cancer Screening ] |
ExamPro Announces OB/GYN Exam-Relevant ACOG Practice Bulletins and Committee Opinions
Thursday, February 23rd, 2012 |
The March ACOG Practice Bulletins (1), and Committee Opinions (3), have been released. They are all to some degree exam-relevant topics. The Practice Bulletin is entitled “Management of Gynecologic Issues in Women With Breast Cancer.” While this is clearly important for OB/GYNs, it is very closely allied to a potential discussion on breast cancer screening [...] [ Read More on ExamPro Announces OB/GYN Exam-Relevant ACOG Practice Bulletins and Committee Opinions ] |
ExamPro Announces OB/GYN Exam-Relevant and Newsworthy Information about LoOvral
Wednesday, February 1st, 2012 |
About one million packages of the birth control pill LoOvral are being recalled due to imprecise dosing of the tablets. The concern is that some tablets may have inadequate amounts of estrogen, which could possibly fail to inhibit ovulation. This could result in the potential for unprotected intercourse and possible consequent pregnancy. The drugs are [...] [ Read More on ExamPro Announces OB/GYN Exam-Relevant and Newsworthy Information about LoOvral ] |
ExamPro Announces Three Significant Changes to OB/GYN MOC Process
Wednesday, February 1st, 2012For those involved in the OB/GYN MOC process, three significant changes have occurred for 2012. They are as follows: 1) The deadline for MOC enrollment is now November 15. Despite this substantial extension, diplomates are encouraged to register as soon as possible – as early as November of the previous year when registration opens. Early [...] [ Read More on ExamPro Announces Three Significant Changes to OB/GYN MOC Process ] |
For OB/GYN Oral Boards: ExamPro Presents Exam Relevant Announcement from ACOG on Labor Induction
Wednesday, January 11th, 2012| |
ACOG President Dr. James Martin recently released a message in the ACOG News publication about labor induction. The basic thrust of this message is that we should continue to make sure not to needlessly induce labor prior to 39 completed weeks. Since the issue of induction is a favorite discussion point in the exam, and [...] [ Read More on For OB/GYN Oral Boards: ExamPro Presents Exam Relevant Announcement from ACOG on Labor Induction ] |
For OB/GYNs Taking The Oral Boards: ExamPro Presents Exam Relevant Information and Updates About “Plan B” Contraceptive
Tuesday, December 6th, 2011 |
The contraceptive “Plan B” has up until now been available to anyone with a prescription or showing proof of being older than 17 years of age. The manufacturers of this drug have now requested that it be sold over the counter without prescription and thus be made available to those under age 17 years of [...] [ Read More on For OB/GYNs Taking The Oral Boards: ExamPro Presents Exam Relevant Information and Updates About “Plan B” Contraceptive ] |
For OB/GYNs Taking The Oral Boards: ExamPro Presents an Exam Relevant Announcement from ACOG
Tuesday, December 6th, 2011| |
The following is a direct quote from Dr. Gerald Joseph, ACOG Vice President, Practice Activities: “All women should receive an annual influenza vaccination; this is particularly important for pregnant and postpartum women. Influenza vaccination is an essential element of prenatal care because pregnant women are at increased risk for serious illness and mortality due to [...] [ Read More on For OB/GYNs Taking The Oral Boards: ExamPro Presents an Exam Relevant Announcement from ACOG ] |
For OB/GYNs Taking The Oral Boards: ExamPro Presents Exam Relevant ACOG Committee Opinions
Tuesday, November 29th, 2011| |
As I’d mentioned in the previous blog, two of the three ACOG Committee Opinions for December should be considered as being highly exam relevant for the OB/GYN Oral Boards. They are: 1) #514: Emergent Therapy for Acute-Onset, Severe Hypertension With Preeclampsia or Eclampsia 2) #513: Vaginal Placement of Synthetic Mesh for Pelvic Organ Prolapse (this [...] [ Read More on For OB/GYNs Taking The Oral Boards: ExamPro Presents Exam Relevant ACOG Committee Opinions ] |
For OB/GYNs Taking The Oral Boards: ExamPro Presents Exam Relevant ACOG Committee Opinions
Tuesday, November 29th, 2011 |
Two of the three ACOG Committee Opinions for December should be considered as being highly exam relevant for the OB/GYN Oral Boards. The salient points of each will be provided in this, and a subsequent blog to be released shortly. They are: #514: Emergent Therapy for Acute-Onset, Severe Hypertension With Preeclampsia or Eclampsia #513: Vaginal [...] [ Read More on For OB/GYNs Taking The Oral Boards: ExamPro Presents Exam Relevant ACOG Committee Opinions ] |
